Chief Science Officer

About the role

Break Through Cancer was founded in 2021 to organize and support outstanding researchers and physicians to intercept and find improved treatments for the deadliest cancers by stimulating highly collaborative science. The Foundation is a partnership among five of the top cancer research centers in the world: Dana-Farber Cancer Institute, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, the Koch Institute for Integrative Cancer Research at MIT, The University of Texas MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center. Over the past five years, funded teams have grown to include scientists and clinicians from more than fifteen institutions, and Break Through Cancer has invested more than $136 million in its scientific portfolio.Focused initially on several of the deadliest cancers, glioblastoma, acute myeloid leukemia, ovarian cancer, and pancreatic cancer, Break Through Cancer’s funded project teams create new approaches to tackle long-standing challenges in cancer. They accelerate the pace of drug approval by bringing preclinical and clinical science together to support learning deeply in patients during clinical trials, incentivize radical collaboration between academia and industry, and invest in software and technologies that strengthen data sharing and analysis across institutions. TeamLabs, multi-institutional groups of scientists, clinicians, engineers, and data experts, are the engine behind this model, supported by a cloud-based Data Science Hub that removes friction from real-time data sharing. The Chief Science Officer (CSO) sets and leads the scientific vision and strategy for Break Through Cancer. The CSO works closely with the President, Leadership Team, Scientific Advisory Board (SAB), and Board of Directors (BoD) to identify high-impact scientific opportunities, build and steward TeamLabs, and convert bold ideas into funded, accountable research programs. The CSO serves as one of the organization’s primary scientific ambassadors, cultivating relationships with academic leaders, industry partners, philanthropic supporters, and the broader oncology community.The CSO leads the process to determine scientific direction for the organization, and represents Break Through Cancer’s scientific vision, along with the President and Chief Data Officer, to the SAB